2.00

0.76% 0.015

After Hours: 1.90 -0.10 -5.00%

Standard Biotools Inc (LAB)

Overview News Price History Option Chain Financials Discussions Forecast

Standard Biotools Inc stock is traded at $2.00, with a volume of 4.48M. It is up +0.76% in the last 24 hours and up +24.22% over the past month. Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Previous Close:

$1.985

Open:

$1.94

24h Volume:

4.48M

Relative Volume:

2.46

Market Cap:

$744.52M

Revenue:

$106.34M

Net Income/Loss:

$-74.66M

P/E Ratio:

-1.8868

EPS:

-1.06

Net Cash Flow:

$-46.12M

1W Performance:

+4.71%

1M Performance:

+24.22%

6M Performance:

+4.17%

1Y Performance:

+3.63%

1-Day Range:

$1.895

$2.05

1-Week Range:

$1.88

$2.25

52-Week Range:

$1.21

$3.04

Standard Biotools Inc Stock (LAB) Company Profile

Name

Standard Biotools Inc

Sector

Healthcare (1176)

Industry

Medical Devices (148)

Phone

(650) 266-6000

Address

2 TOWER PLACE, SOUTH SAN FRANCISCO

Employee

539

Twitter

Next Earnings Date

2024-10-30

Latest SEC Filings

LAB's Discussions on Twitter

Compare LAB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LAB Standard Biotools Inc	2.00	744.52M	106.34M	-74.66M	-46.12M	-0.95
ABT Abbott Laboratories	114.23	198.13B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	364.60	138.99B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	88.95	131.10B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	81.03	103.90B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	74.81	44.12B	6.60B	4.16B	490.10M	6.93

Standard Biotools Inc Stock (LAB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-16-24	Initiated	TD Cowen	Buy
Apr-04-24	Initiated	Jefferies	Buy
Jul-12-23	Initiated	KeyBanc Capital Markets	Overweight

Standard Biotools Inc Stock (LAB) Latest News

05:05 AM

Standard BioTools Inc. (NASDAQ:LAB) Position Decreased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

05:05 AM

Dec 20, 2024

Standard BioTools Inc. (NASDAQ:LAB) Shares Purchased by Barclays PLC - MarketBeat

Dec 20, 2024

Dec 19, 2024

Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Dec 19, 2024

Standard BioTools CEO to Present at J.P. Morgan Healthcare Conference 2024 - StockTitan

Dec 19, 2024

Dec 18, 2024

Standard BioTools (NASDAQ:LAB) Trading Down 6.8%Here's What Happened - MarketBeat

Dec 18, 2024

BNP Paribas Financial Markets Lowers Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World

Dec 18, 2024

Dec 17, 2024

After Leaping 35% Standard BioTools Inc. (NASDAQ:LAB) Shares Are Not Flying Under The Radar - Simply Wall St

Dec 17, 2024

Dec 16, 2024

Standard BioTools (NASDAQ:LAB) Shares Up 9.9%Still a Buy? - MarketBeat

Dec 16, 2024

What Are You Thinking About Investing In Standard BioTools Inc (NASDAQ: LAB) Stock? - Stocks Register

Dec 16, 2024

Dec 14, 2024

Standard BioTools Inc. (NASDAQ:LAB) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat

Dec 14, 2024

Nov 30, 2024

Standard BioTools (STU:FLB) Enterprise Value : €386.4 Mil (As of Nov. 30, 2024) - GuruFocus.com

Nov 30, 2024

LAB Stock Price and Chart — NASDAQ:LAB - TradingView

Nov 30, 2024

Standard BioTools Inc. (NASDAQ:LAB) Short Interest Down 24.9% in November - MarketBeat

Nov 30, 2024

Standard BioTools (NASDAQ:LAB) Shares Gap UpShould You Buy? - MarketBeat

Nov 30, 2024

Nov 28, 2024

Standard BioTools (NASDAQ:LAB) adds US$78m to market cap in the past 7 days, though investors from three years ago are still down 59% - Simply Wall St

Nov 28, 2024

Nov 18, 2024

Sumitomo Mitsui Trust Group Inc. Decreases Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat

Nov 18, 2024

Nov 15, 2024

Indaba Capital Management L.P. Acquires New Stake in Standard Bi - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Creative Planning Purchases Shares of 20,328 Standard BioTools Inc. (NASDAQ:LAB) - Defense World

Nov 14, 2024

Nov 08, 2024

Standard BioTools names new CFO By Investing.com - Investing.com Australia

Nov 08, 2024

ARK Investment Management LLC Lowers Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat

Nov 08, 2024

Nov 07, 2024

Standard BioTools (STU:FLB) Price-to-Operating-Cash-Flow : (As of Nov. 07, 2024) - GuruFocus.com

Nov 07, 2024

Standard BioTools (STU:FLB) Revenue per Share : €0.67 (TTM As of Sep. 2024) - GuruFocus.com

Nov 07, 2024

Standard BioTools Names Co-Founder Alex Kim as CFO, Brings 30-Year Industry Expertise | LAB Stock News - StockTitan

Nov 07, 2024

Nov 06, 2024

Form 10-Q STANDARD BIOTOOLS INC. For: Sep 30 - StreetInsider.com

Nov 06, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Standard BioTools Inc - GuruFocus.com

Nov 05, 2024

Nov 02, 2024

Earnings Release: Here's Why Analysts Cut Their Standard BioTools Inc. (NASDAQ:LAB) Price Target To US$3.17 - Yahoo Finance

Nov 02, 2024

Nov 01, 2024

TD Cowen trims Standard BioTools target, sees upside in margins and SomaScan performance - Investing.com Australia

Nov 01, 2024

Standard BioTools Q3 2024 Earnings Preview - MSN

Nov 01, 2024

Standard BioTools Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 01, 2024

Oct 31, 2024

Earnings call: Standard BioTools faces mixed Q3 results amid market challenges - Investing.com Australia

Oct 31, 2024